Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma.

Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma. Minerva Endocrinol. 2020 Jul 03;: Authors: Cabiati M, Gaggini M, De Simone P, Basta G, Gastaldelli A, Del Ry S PMID: 32623844 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32623844?dopt=Abstract

Source: Minerva Endocrinologica - July 8, 2020 Category: Endocrinology Tags: Minerva Endocrinol Source Type: research

More News: Cancer & Oncology | Carcinoma | Endocrinology | Hepatocellular Carcinoma | Liver Cancer